non muscle invasive bladder cancer
Showing 1 - 12 of 12
Non Muscle Invasive Bladder Cancer, Urologic Cancer, Bladder Cancer Trial (Cretostimogene Grenadenorepvec,
Not yet recruiting
- Non Muscle Invasive Bladder Cancer
- +3 more
- Cretostimogene Grenadenorepvec
- n-dodecyl-B-D-maltoside
- (no location specified)
Oct 30, 2023
Analytical Specificity of Bladder EpiCheck Test in Healthy
Completed
- Non Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Urothelial Carcinoma
- Bladder EpiCheck
-
San Antonio, TexasUrology San Antonio
Sep 3, 2023
Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive
Recruiting
- Non Muscle Invasive Bladder Cancer
- N803 plus Bacillus Calmette-Guerin (BCG)
-
Honolulu, HawaiiIsland Urology
Aug 7, 2023
Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER
Recruiting
- Urothelial Carcinoma
- +2 more
-
Recife, Pernambuco, Brazil
- +6 more
Jul 11, 2023
Non Muscle Invasive Bladder Cancer Trial in Korea, Republic of, United States (CG0070, Pembrolizumab Injection,
Recruiting
- Non Muscle Invasive Bladder Cancer
- CG0070
- +2 more
-
Phoenix, Arizona
- +20 more
Jun 16, 2022
Non Muscle Invasive Bladder Cancer Trial in Lausanne (Ty21a)
Recruiting
- Non Muscle Invasive Bladder Cancer
- Ty21a
-
Lausanne, Vaud, SwitzerlandDpt Urology- CHUV
Apr 27, 2021
Non Muscle Invasive Bladder Cancer Trial in Seoul (Nanoxel®M, Mitomycin-C)
Terminated
- Non Muscle Invasive Bladder Cancer
-
Seoul, Korea, Republic ofSeoul National University Hospital
Aug 28, 2019
Non Muscle Invasive Bladder Cancer Trial in Genoa, Imperia (Narrow band imaging transurethral resection, Standard transurethral
Completed
- Non Muscle Invasive Bladder Cancer
- Narrow band imaging transurethral resection
- Standard transurethral resection
-
Genoa, Italy
- +1 more
Jan 13, 2018
Non Muscle Invasive Bladder Cancer, Treatment by BCG Trial in Toulouse (Xpert bladder Test)
Unknown status
- Non Muscle Invasive Bladder Cancer
- Treatment by BCG
- Xpert bladder Test
-
Toulouse, FranceInstitut claudius regaud IUCT ONCOPOLE
Sep 8, 2016
Non Muscle Invasive Bladder Cancer Trial in Nahariya (TC-3 hydrogel)
Withdrawn
- Non Muscle Invasive Bladder Cancer
- TC-3 hydrogel
-
Nahariya, IsraelWestern Galilee Hospital Nahariya
Aug 30, 2015
Carcinoma in Situ, Non Muscle Invasive Bladder Cancer Trial in United States (TMX-101)
Completed
- Carcinoma in Situ
- Non Muscle Invasive Bladder Cancer
-
Phoenix, Arizona
- +3 more
Feb 9, 2015